Your browser doesn't support javascript.
loading
Successful ruxolitinib administration for a patient with steroid-refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review.
Tomomasa, Dan; Isoda, Takeshi; Mitsuiki, Noriko; Yamashita, Motoi; Morishita, Aoi; Tomoda, Takahiro; Okano, Tsubasa; Endo, Akifumi; Kamiya, Takahiro; Yanagimachi, Masakatsu; Imai, Kohsuke; Kanegane, Hirokazu; Takagi, Masatoshi; Morio, Tomohiro.
Afiliação
  • Tomomasa D; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Isoda T; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Mitsuiki N; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Yamashita M; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Morishita A; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Tomoda T; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Okano T; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Endo A; Clinical Research Center Tokyo Medical and Dental University Tokyo Japan.
  • Kamiya T; Clinical Research Center Tokyo Medical and Dental University Tokyo Japan.
  • Yanagimachi M; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
  • Imai K; Department of Hematology and Oncology Kanagawa Children's Medical Center Yokohama Japan.
  • Kanegane H; Department of Community Pediatrics, Perinatal and Maternal Medicine Tokyo Medical and Dental University Tokyo Japan.
  • Takagi M; Department of Child Health and Development Tokyo Medical and Dental University Tokyo Japan.
  • Morio T; Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan.
Clin Case Rep ; 9(12): e05242, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34987813
Idiopathic pneumonia syndrome (IPS) is an acute lung complication observed after the early posthematopoietic stem cell transplantation (HSCT) period. Ruxolitinib was effective for a patient with myelodysplastic syndrome who developed severe IPS after second HSCT. No severe adverse effects were observed. Ruxolitinib may be an alternative choice for HSCT-related IPS.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Clin Case Rep Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Clin Case Rep Ano de publicação: 2021 Tipo de documento: Article